Clinical reviews further document an increased IL-10/TNF-α ratio in obesity as a homeostatic brake on inflammation [19], and inflamed adipose depots concurrently express other anti-inflammatory mediators (e.g., IL-19), underscoring the shift away from TNF-α secretion in advanced adiposity [20]. The gene discussed is IL19; the disease is obesity disorder.